HOME >> MEDICINE >> NEWS
From smoking to sumatriptan, researchers present important new findings on the impacts of drug metabolism

LOS ANGELES -- Pharmacologists from across the country and around the world will offer more than 350 presentations during the American Society for Clinical Pharmacology and Therapeutics annual meeting March 15-18 at the Century Plaza Hotel & Tower. They include:

Why do Chinese-Americans smoke less than whites?

It's one of the major curiosities in smoking behavior -- why one smoker is content with one or two cigarettes a day but another craves a pack a day or more. New research from Rachel Tyndale, MD, and her colleagues at the University of Toronto indicates that people with defects in the CYP2A6 gene tend to smoke about one-third fewer cigarettes per day than people without the defects. People with CYP2A6 defects metabolize nicotine slower, so they don't smoke as much. Neal Benowitz, MD, and colleagues at the University of California at San Francisco report that slow metabolism of nicotine due to CYP2A6 defects may explain why Chinese-Americans smoke less than whites. (Oral presentations)

Sweet News for Sickle Cell Anemia Sufferers

The artificial sweetener aspartame has been reported to be effective in counteracting the effects of abnormal hemoglobin that reduce oxygen in red blood cells, causing sickle cell anemia. However, appropriate doses for clinical use have not been determined. In a new study of 24 patients, researchers from Oklahoma Medical Research Foundation and Oklahoma University Health Sciences Center have determined an amount that remains effective for eight hours or longer. The findings are good news for sickle cell anemia patients, as few treatment drugs are available. (Poster PI-55).

Quick Relief for Adolescents with Migraine

Adults plagued by migraine headache have been able to obtain quick relief with a nasal spray of the drug sumatriptan since 1997. But that doesn't help the 8 million children and adolescents who suffer from migraines since clinicians have been uncertain about amounts
'"/>

Contact: Kirk Monroe
kmcpr@aol.com
202-789-8101
K-M Communications
14-Mar-2000


Page: 1 2

Related medicine news :

1. NHS stop-smoking services are insufficient to deliver national smoking targets
2. Study suggests smoking while pregnant may increase chromosomal abnormalities in fetal cells
3. Current daily smoking may be associated with increased risk for suicidal thoughts and attempts
4. School-based smoking prevention programs ineffective
5. Parents who quit smoking may influence their offspring to quit as young adults
6. Inpatient smoking cessation counseling is associated with early differences in mortality
7. NHLBI study shows smoking cessation programs improve survival
8. 14-year study finds that quitting smoking adds years to life
9. Campus can be effective site for anti-smoking efforts
10. Contrary to previous findings, smoking is detrimental to patients with Alzheimers
11. State policies decrease youth smoking, drinking and sex

Post Your Comments:
(Date:5/5/2015)... Alachua, FL (PRWEB) May 05, 2015 ... technology company focused on the $1.6 billion peripheral nerve ... the first quarter ended March 31, 2015 compared to ... “The market’s continued adoption of our proprietary portfolio of ... Nerve Connector and AxoGuard® Nerve Protector – and our ...
(Date:5/5/2015)... 2015 Leveraging the industry-leading technology found ... an experienced team of fertility specialists are committed to ... around the globe. , “We’re honored that Maternity Health ... a global leader in reproductive medicine. The clinic offers ... in the world who play an important role in ...
(Date:5/5/2015)... global lab automation market is expected to reach $5,105.7 ... an estimated CAGR of 6.7% from 2015 to 2020. ... basis of equipment and software, application, type of automation, ... Lab Automation Market is classified into clinical diagnostics, drug ... a major application of the lab automation market. Developing ...
(Date:5/5/2015)... 05, 2015 Hundreds of ... on behalf of men who allegedly suffered ... of prescription testosterone replacement therapies continue to ... underway in U.S. District Court, Northern District ... May 1st, defendants AbbVie, Inc., Auxilium Pharmaceuticals, ...
(Date:5/5/2015)... Viverae®, a health management and engagement ... multinational developer, manufacturer and marketer of innovative, life-enhancing ... oncology and surgical specialty products, as the recipient ... Award recognizes outstanding achievement in the design and ... client base. , Viverae reviewed the employee wellness ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2
(Date:5/5/2015)... 2015 Ardelyx, Inc. (NASDAQ: ARDX ... gastrointestinal, and metabolic diseases, today announced that a ... Stage 3 chronic kidney disease patients with type ... the primary endpoint of decreasing the urinary albumin-creatinine ... placebo. Ardelyx formed a partnership ...
(Date:5/5/2015)... -- (Family Features) Which health screenings and exams are ... monitoring your weight, cholesterol, and blood pressure is probably ... vision care? Photo - http://photos.prnewswire.com/prnh/20150505/213909 ... they often start to notice small changes in their ... performance. Whether having difficulty reading a book or working ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... addition of the "Electro Surgical Market" ... electrosurgical market is expected to achieve a CAGR ... surgery offer huge benefits for patients as well ... surgery infections, condensed visible marks, bleeding control and ...
Breaking Medicine Technology:Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4Global Electro Surgical Market 2015 2
Cached News: